Innovation - pharmacologie - ingénierie tissulaire

Type: Evaluation report on federative structures

Evaluation campaign: 2010-2011 (group B) - Published on: 28/10/2011

Institution(s) concerned: Université de Poitiers , Centre national de la recherche scientifique - CNRS , Institut national de la santé et de la recherche médicale - INSERM

Disciplinary research field: Life and Earth Sciences (SVE) ; SVE5 Physiology, Physiopathology, Cardiology, Pharmacology, Enocrinology, Cancer, Medical Technologies

ERC panel(s): LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome ; LS1 Molecular and Structural Biology and Biochemistry: molecular biology, biochemistry, biophysics, structural biology, biochemistry of signal transduction ; LS2 Genetics, Genomics, Bioinformatics and Systems Biology: genetics, population genetics, molecular genetics, genomics, transcriptomics, proteomics, metabolomics, bioinformatics, computational biology, biostatistics, biological modelling and simulation, systems biology, genetic epidemiology ; LS3 Cellular and Developmental Biology: cell biology, cell physiology, signal transduction, organogenesis, developmental genetics, pattern formation in plants and animals ; LS5 Neurosciences and neural disorders: neurobiology, neuroanatomy, neurophysiology, neurochemistry, neuropharmacology, neuroimaging, systems neuroscience, neurological disorders, psychiatry ; LS6 Immunity and infection: immunobiology, aetiology of immune disorders, microbiology, virology, parasitology, global and other infectious diseases, population dynamics of infectious diseases, veterinary medicine ; LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics